日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Long non-coding rnas as key modulators of the immune microenvironment in hepatocellular carcinoma: implications for Immunotherapy

长链非编码RNA作为肝细胞癌免疫微环境的关键调节因子：对免疫治疗的启示

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1523190
Zhao, Siqi; Chen, Fei; Hu, Lingyu; Li, Xiaoping; Gao, Zhaofeng; Chen, Minjie; Wang, Xiaoguang; Song, Zhengwei
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Reversing VTN deficiency inhibits the progression of pancreatic cancer and enhances sensitivity to anti-PD1 immunotherapy

逆转VTN缺陷可抑制胰腺癌的进展并增强对PD-1抗体免疫疗法的敏感性

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1578870
Zhao, Siqi; Gao, Zhaofeng; Hu, Lingyu; Li, Yihan; Wang, Xiaoguang; Li, Xiaoping; Chen, Minjie; Chen, Fei; Song, Zhengwei
肿瘤
肿瘤免疫
胰腺癌
PD-1
免疫/内分泌
发表日期：2025
文献求助 收藏

PD-L1 expression and its association with clinicopathological and computed tomography features in surgically resected non-small cell lung cancer: a retrospective cohort study

PD-L1表达及其与手术切除的非小细胞肺癌的临床病理学和计算机断层扫描特征的相关性：一项回顾性队列研究

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-025-10437-9
Wang, Shiwei; Xu, Mingyue; Liu, You; Hou, Xiaoming; Gao, Zhaofeng; Sun, Jingjie; Shen, Leilei
肺癌
肿瘤
肿瘤免疫
PD-L1
细胞生物学
发表日期：2025
文献求助 收藏

Predicting sentinel lymph node metastasis in breast cancer: a study based on the SEER database

预测乳腺癌前哨淋巴结转移：一项基于SEER数据库的研究

期刊:Clinical and Experimental Medicine
影响因子:3.5
doi:10.1007/s10238-025-01591-5
Li, Qingyang; Xu, Hu; Bao, Baoshi; Xie, Yujiao; Guo, Shiqi; Gao, Zhaofeng; Chen, Siyi; Sun, Jiahong; Zhu, Li; Wang, Jiandong
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Prediction of lymphovascular invasion in non-mass enhancement breast cancer using DCE-MRI and clinical-pathological features

利用动态增强磁共振成像和临床病理特征预测非肿块增强型乳腺癌的淋巴血管侵犯

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1539748
Guo, Shiqi; Zhao, Kai; Xu, Hu; Xie, Yujiao; Li, Qingyang; Liang, Junqing; Chen, Siyi; Sun, Jiahong; Gao, Zhaofeng; Zhu, Li; Wang, Jiandong
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

To treat or not to treat? Adjuvant chemotherapy in 46 patients with stage IB lung squamous cell carcinoma: a real-world matched analysis

治疗还是不治疗？46例IB期肺鳞状细胞癌患者的辅助化疗：一项真实世界匹配分析

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1647649
Liang, Botao; Fu, Tingting; Guo, Juntang; Zhang, Lianbin; Liang, Chaoyang; Zhang, Tao; Zhao, Kai; Gao, Zhaofeng; Yang, Jing; Shen, Leilei
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

The multifaceted functions of SPC25 in cancer: from molecular pathways to targeted therapy

SPC25在癌症中的多重功能：从分子通路到靶向治疗

期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2025.1550901
Jin, Yigang; Chen, Minjie; Chen, Fei; Gao, Zhaofeng; Li, Xiaoping; Hu, Lingyu; Cai, Dandan; Zhao, Siqi; Song, Zhengwei
信号转导
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

The up-regulation of SPTAN1 expression in Pancreatic adenocarcinoma is associated with tumor immune invasion and poor clinical prognosis

胰腺腺癌中SPTAN1表达上调与肿瘤免疫侵袭和不良临床预后相关。

期刊:BMC Gastroenterology
影响因子:2.6
doi:10.1186/s12876-024-03581-5
Guo, Wei; Hu, LingYu; Gao, ZhaoFeng; Liu, XiaoRong; Yang, XiaoDan; Wang, XiaoGuang
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

α-Asarone attenuates tumor-associated macrophages-induced gemcitabine resistance in pancreatic carcinoma via the transforming growth factor-beta 1/growth factor independent 1 axis.

α-细辛脑通过转化生长因子-β1/生长因子非依赖性1轴减弱肿瘤相关巨噬细胞诱导的胰腺癌吉西他滨耐药性

期刊:Anti-Cancer Drugs
影响因子:2.2
doi:10.1097/CAD.0000000000001740
Yu Jiaqi, Xue Yuzhe, Gao Zhaofeng, Hu Lingyu, Liu Xiaorong, He Xuesong, Wang Xiaoguang
细胞生物学
肿瘤
胰腺癌
巨噬细胞
发表日期：2025
文献求助 收藏

PD1/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectives

PD1/PD-L1阻断疗法在透明细胞肾细胞癌中的应用：机制解析、临床疗效及未来展望

期刊:Molecular Cancer
影响因子:33.9
doi:10.1186/s12943-024-02059-y
Zhu, Zhaoyang; Jin, Yigang; Zhou, Jing; Chen, Fei; Chen, Minjie; Gao, Zhaofeng; Hu, Lingyu; Xuan, Jinyan; Li, Xiaoping; Song, Zhengwei; Guo, Xiao
肿瘤
肿瘤免疫
肾癌
PD-L1
细胞生物学
发表日期：2024
文献求助 收藏